Research Topics
| M E BigalSummaryAffiliation: Albert Einstein College of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinicM E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
Cephalalgia 27:230-4. 2007..In the population where use of specific acute migraine medications is less common, the agreement between ICHD-2R CM and TM may be less robust...
Migraine days decline with duration of illness in adolescents with transformed migraineM E Bigal
Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA
Cephalalgia 25:482-7. 2005..These findings suggest that early in the process of transformation, migraine is more frequent, and that as CDH evolves, fewer typical attacks of IHS migraine occur...
Obesity is a risk factor for transformed migraine but not chronic tension-type headacheMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 67:252-7. 2006..To assess the influence of the body mass index (BMI) on the prevalence and severity of chronic daily headache (CDH) and its most frequent subtypes, transformed migraine (TM) and chronic tension-type headache (CTTH)...
Age-dependent prevalence and clinical features of migraineMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 67:246-51. 2006..Available data suggest two seemingly opposite trends with regard to the natural history of migraine. Migraine prevalence decreases with age. In some individuals, migraine progresses to chronic daily headache...
The preventive treatment of migraineMarcelo E Bigal
Departments of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
Neurologist 12:204-13. 2006..Migraine is a common, chronic, and disabling disorder. The treatment of migraine includes a combination of nonpharmacologic and pharmacologic techniques. Pharmacologic approaches are subdivided in preventive therapies and acute care...
Epilepsy and migraineM E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Epilepsy Behav 4:S13-24. 2003..We summarize the epidemiologic evidence that migraine and epilepsy are associated and discuss specific interrelationships between migraine and epilepsy...
The epidemiology and impact of migraineMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Curr Neurol Neurosci Rep 4:98-104. 2004..Probable migraine is a prevalent form of migraine, and like migraine with and without aura it produces decrements in health-related quality of life and increments in disability relative to control subjects...
Field testing alternative criteria for chronic migraineM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Cephalalgia 26:477-82. 2006..Consistently, criteria for CM and CM+ should be revised to require at least 8 days of migraine or probable migraine per month, in individuals with 15 or more days of headache per month...
Headache prevention outcome and body mass indexM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Cephalalgia 26:445-50. 2006..Contrary to what we hypothesized, obesity at baseline does not seem to be related to follow-up refractoriness to preventive treatment...
Prophylactic migraine therapy: emerging treatment optionsMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
Curr Pain Headache Rep 8:178-84. 2004..Data are presented on topiramate, levetiracetam, zonisamide, botulinim toxin, tizanidine, nefazodone, lisinopril, candesartan, carabersat, petasites, and coenzyme Q...
Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomesM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
Cephalalgia 24:483-90. 2004..001). More rigorous prescribing guidelines for patients with frequent headaches are urgently needed. Successful detoxification is necessary to ensure improvement in the headache status when treating patients who overuse acute medications...
Primary chronic daily headache and its subtypes in adolescents and adultsM E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
Neurology 63:843-7. 2004..To determine the relative frequency of chronic daily headache (CDH) subtypes in adolescents and to compare the distribution of CDH subtypes in adolescents and adults of various ages...
Obesity and migraine: a population studyMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 66:545-50. 2006..To assess the influence of body mass index (BMI) on the prevalence, attack frequency, and clinical features of migraine...
Chronic migraine is an earlier stage of transformed migraine in adultsM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 65:1556-61. 2005..They are often classified as transformed migraine (TM), a disorder not addressed in the International Headache Society classification...
Tension-type headache: classification and diagnosisMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
Curr Pain Headache Rep 9:423-9. 2005..A structured approach to the patient and a better comprehension of this variability of presentation should translate into better quality of care and a more specific diagnosis for TTH sufferers...
When migraine progresses: transformed or chronic migraineMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Expert Rev Neurother 6:297-306. 2006..The risk factors for migraine progression and the mechanisms for progression will be discussed. This review concludes with the prospects for treating transformed migraine and avoiding migraine progression...
Obesity and chronic daily headacheMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
Curr Pain Headache Rep 12:56-61. 2008..We then review the potential pathophysiologic mechanisms to support this relationship. We close by briefly discussing clinical interventions related to obesity and migraine...
Treatment of comorbidities of chronic daily headacheSait Ashina
Marcelo E Bigal, MD, PhD Department of Neurology and the Montefiore Headache Center, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Rousso Building, Room 330, Bronx, NY 10461, USA
Curr Treat Options Neurol 10:36-43. 2008..Those with high risk of progression will be more aggressively treated, not just to relieve current pain and disability but to prevent progression. Therefore, treatment will focus on decreasing current burden and preventing future burden...
Migraine at all agesMarcelo E Bigal
Albert Einstein College of Medicine, Department of Neurology, 1165 Morris Park Avenue, Bronx, NY 10451, USA
Curr Pain Headache Rep 10:207-13. 2006..Clarifying the influence of age on migraine is of importance for clinical diagnosis and treatment. It also may contain clues to evolving disease biology...
Body mass index and episodic headaches: a population-based studyMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Arch Intern Med 167:1964-70. 2007....
The differential diagnosis of chronic daily headaches: an algorithm-based approachMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Rousso Bldg, Room 330, Bronx, NY 10461, USA
J Headache Pain 8:263-72. 2007..The clinical approach to diagnosing CDH is the scope of this review...
Migraine in adolescents: association with socioeconomic status and family historyM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Neurology 69:16-25. 2007..The influence of socioeconomic status on the prevalence of migraine is unknown in adolescents. Accordingly, we investigated the prevalence of migraine in a large sample of adolescents by sociodemographic features...
New developments in migraine prophylaxisMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, New York, USA
Expert Opin Pharmacother 4:433-43. 2003..The aim of this review is to present and discuss the new options for migraine prevention...
Ergotamine and dihydroergotamine: a reviewMarcelo E Bigal
The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
Curr Pain Headache Rep 7:55-62. 2003..In patients with status migrainous and patients with frequent headache recurrence, ergotamine is still probably useful...
The medical management of migraineMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
Am J Ther 11:130-40. 2004..The clinicians have in their armamentariums an ever-expanding variety of medications. With experience, clinicians can match individual patient needs with the specific characteristics of a drug to optimize therapeutic benefit...
Obesity, migraine, and chronic migraine: possible mechanisms of interactionMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Neurology 68:1851-61. 2007..Dysfunction in the orexins pathways seems to be a risk factor for both conditions. Finally, conditions that are comorbid to both states (e.g., depression, sleep apnea) may also make the relationship between both diseases more complex...
The prognosis of migraineMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
Curr Opin Neurol 21:301-8. 2008..In many, migraine may have a very benign (complete remission) or relatively benign (partial remission) prognosis. In some, migraine persists and in others, it progresses...
Prevalence and impact of migraine and probable migraine in a health planN V Patel
AdvancePCS, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Neurology 63:1432-8. 2004..A large number of headache sufferers with features of migraine fail to meet criteria for strict migraine (SM; migraine with or without aura) but do meet criteria for probable migraine (PM)...
Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind studyA M Rapoport
Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Neurology 69:821-6. 2007..To evaluate the efficacy and tolerability of zolmitriptan 5 mg and 10 mg nasal spray (ZNS) vs placebo in the acute treatment of cluster headache. Design/..
Classification of primary headachesR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461 1926, USA
Neurology 63:427-35. 2004..They conclude by presenting an approach to headache diagnosis based upon these criteria...
Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerationsM Volcy
The New England Centre for Headache, Stamford, CT 06902-1251, USA
Cephalalgia 26:336-40. 2006
Familial risk of migraine: variation by proband age at onset and headache severityW F Stewart
Center for Health Research and Rural Advocacy, Geisinger Health System, Baltimore, MD, USA
Neurology 66:344-8. 2006..56 to 3.62) compared with 1.52 (0.99 to 2.34) for less severe pain (p < 0.05). CONCLUSION: Early onset of migraine in the proband as well as the severity of migraines are associated with higher levels of family aggregation...
Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of lifeR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Neurology 65:S50-8. 2005..We consider clinical trials strategies designed to address the more complex clinical and policy requirements for meeting the needs of those with migraine...
Migraine preventive therapy: current and emerging treatment optionsA M Rapoport
The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902 1251, USA
Neurol Sci 26:s111-20. 2005..In this paper we review new treatment options for migraine prevention. We start with an overview about migraine and then briefly discuss current indications for migraine prevention and new and emerging preventive medications...
Patterns of health care utilization for migraine in England and in the United StatesR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Neurology 60:441-8. 2003..To assess patterns of medical consultation, diagnosis, and medication use in representative samples of adults with migraine in England and the United States...
Prevalence and characteristics of allodynia in headache sufferers: a population studyM E Bigal
Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 70:1525-33. 2008..The authors estimated the prevalence and severity of cutaneous allodynia (CA) in individuals with primary headaches from the general population...
The family impact of migraine: population-based studies in the USA and UKR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Cephalalgia 23:429-40. 2003..02), with their level or responsibilities and duties (P = 0.02), and with their ability to perform (P = 0.001). Results from this study show that the impact of migraine extends to household partners and other family members...
Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headacheM E Bigal
Department of Neurology, Albert Einstein College of Medicine, USA
Cephalalgia 22:432-8. 2002..The Silberstein and Lipton system is easier to apply, and more parsimonious. These findings support revision of the IHS classification system to include chronic migraine...
Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combinationR B Lipton
Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Neurology 63:1099-101. 2004..The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches...
Migraine prevalence, disease burden, and the need for preventive therapyR B Lipton
Department of Neurology, The Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Neurology 68:343-9. 2007....
New daily persistent headache in the paediatric populationE Kung
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Cephalalgia 29:17-22. 2009..On most days, they had migraine-associated symptoms (one of nausea, photophobia or phonophobia)). NDPH is common in children and adolescents with CDH. Most subjects do not overuse medication. Migraine features are common...
MMPI personality profiles in patients with primary chronic daily headache: a case-control studyM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Rousso Building, 1165 Morris Park Avenue, Bronx, NY 10461, USA
Neurol Sci 24:103-10. 2003....
Persistent idiopathic facial pain responsive to topiramateM Volcy
The New England Center for Headache, Stamford, CT 06902, USA
Cephalalgia 26:489-91. 2006
Patterns of medical diagnosis and treatment of migraine and probable migraine in a health planM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, NY, USA
Cephalalgia 26:43-9. 2006..Educational strategies should focus on physician education addressing diagnosing the full spectrum of migraine and physician management of migraine with specific migraine therapy in appropriate patients...
Why headache treatment failsR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY10461, USA
Neurology 60:1064-70. 2003..Persistence in treating these patients can be very rewarding. The authors provide a checklist intended to facilitate the management of refractory patients...
Post-traumatic headache: emphasis on chronic types following mild closed head injuryF D Sheftell
New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
Neurol Sci 28:S203-7. 2007..This is perhaps as it should be given that the best practice combines knowledge of the evidence with individual clinical experience...
Migraine headache disability and health-related quality-of-life: a population-based case-control study from EnglandR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA
Cephalalgia 23:441-50. 2003..Specifically, individuals classified with moderate to severe work-related disability had lower HRQoL scores than those classified with low disability...
Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a reviewR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
Cephalalgia 24:321-32. 2004....
Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)--a case reportM Volcy
The New England Center for Headache, Stamford, CT 06902, USA
Cephalalgia 25:470-2. 2005
Migraine practice patterns among neurologistsR B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Neurology 62:1926-31. 2004..To assess the attitudes, knowledge, and practice patterns of US neurologists regarding migraine management relative to the US Headache Consortium Guidelines (the Guidelines)...
Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraineM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Cephalalgia 29:1188-96. 2009..0 vs. -1.3 mmHg) and high-density lipoprotein cholesterol (-3.7 vs. -0.8 mg/dl). Increased weight during migraine treatment is not associated with poor headache treatment outcomes, but is associated with deterioration of CVD risk markers...
Migraine and cardiovascular disease: possible mechanisms of interactionM E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 72:1864-71. 2009..Ultimately, it will be important to determine whether MA is a modifiable risk factor for CVD and if preventive medications for migraine or antiplatelet therapy might reduce the risk of CVD in patients with MA...
Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteriaC Sun-Edelstein
The New York Headache Center, New York, NY 10021, USA
Cephalalgia 29:445-52. 2009..We aimed to explain the nature of the controversies surrounding the entities of CM and MOH. A clinical case will be used to illustrate some of the problems faced by clinicians in diagnosing patients with chronic daily headache...
Which triptan for which patient?A M Rapoport
Department of Neurology, Columbia University, New York, NY, USA
Neurol Sci 27:S123-9. 2006..New studies have looked at early treatment paradigms and result in better efficacy data, but are difficult to compare due to different endpoints...
Migraine and adiponectin: is there a connection?B L Peterlin
Department of Neurology, Drexel University College of Medicine, Philadelphia, PA 19102, USA
Cephalalgia 27:435-46. 2007..Future research may focus on how adiponectin levels are potentially altered during migraine attacks, and how that information can be potentially translated into migraine therapy...
Validity and reliability of the Migraine-Treatment Optimization QuestionnaireR B Lipton
Department of Neurology, Albert Einstein College of Medicine, New York, NY 10461, USA
Cephalalgia 29:751-9. 2009..66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-15) and primary care (M-TOQ-5) should be further validated...
Cutaneous allodynia in the migraine populationRichard B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Ann Neurol 63:148-58. 2008..To develop and validate a questionnaire for assessing cutaneous allodynia (CA), and to estimate the prevalence and severity of CA in the migraine population...
Chronic disorders with episodic manifestations: focus on epilepsy and migraineSheryl R Haut
Comprehensive Epilepsy Management Center, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY 10467 2490, USA
Lancet Neurol 5:148-57. 2006..This investigation draws attention to unique aspects of both epilepsy and migraine, while identifying areas of crossover in which each specialty could benefit from the experience of the other...
The triptan formulations: a critical evaluationMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Arq Neuropsiquiatr 61:313-20. 2003....
Chronic pain and obesity in elderly people: results from the Einstein aging studyLucas H McCarthy
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
J Am Geriatr Soc 57:115-9. 2009..To determine the prevalence of chronic pain in elderly people and its relationship with obesity and associated comorbidities and risk factors...
Headache: triumphs in translational researchRichard B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Lancet Neurol 4:11-2. 2005
The epidemiology of migraineRichard B Lipton
Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA
Am J Med 118:3S-10S. 2005..However, prevalence is high in groups other than these high-risk groups. In a subgroup of patients, migraine may be a progressive disorder...
Hemicrania continua: comparison between two different classification systemsM E Bigal
The New England Center for Headache, Stamford, Connecticut, USA
Cephalalgia 22:242-5. 2002..the Goadsby and Lipton classification is more clinically useful and should be included in future International Headache Society reclassification...
Migraine: barriers for careF D Sheftell
The New England Center for Headache, 778 Long Ridge Road, Stamford, CT, USA
Neurol Sci 26:s140-2. 2005....
Occipital levels of GABA are related to severe headaches in migraineM E Bigal
Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 70:2078-80. 2008
The patent foramen ovale-migraine questionS J Tepper
The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
Neurol Sci 28:S118-23. 2007..One reported secondary endpoint showed a significant 42% reduction of migraine days, suggesting the need for further randomised, sham-controlled PFO closure studies...
Ten lessons on the epidemiology of migraineRichard B Lipton
Montefiore Headache Unit, Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Headache 47:S2-9. 2007....
Clinical course in migraine: conceptualizing migraine transformationMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Neurology 71:848-55. 2008..Herein we discuss the evidence that migraine may transform and then consider potential mechanisms as well as risk factors. We close with a brief discussion of clinical strategies that arise based on this perspective on migraine...
Migraine: epidemiology, impact, and risk factors for progressionRichard B Lipton
Department of Neurology, Albert Einstein College of Medicine and Montefiore Headache Unit, Bronx, NY 10461, USA
Headache 45:S3-S13. 2005..Future epidemiologic studies should focus on identifying patients who are at higher risk for progression and on assessing the impact of intervention strategies on disease progression...
Intranasal medications for the treatment of migraine and cluster headacheAlan M Rapoport
Columbia University College of Physicians and Surgeons, New York, NY, USA
CNS Drugs 18:671-85. 2004..Nevertheless, it is our opinion that nasal preparations increase therapeutic options and may result in faster response times and better efficacy than oral formulations and better patient satisfaction than injectable preparations...
Hemicrania continua: clinical and nosographic updateA M Rapoport
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Neurol Sci 24:S118-21. 2003..HC will be addressed in the 2003 revision of the International Headache Society (IHS). In this paper we review the clinical features, classification and treatment of HC...
Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind studyM E Bigal
Departmet of Neurology, Albert Einstein School of Medicine, Bronx, NY, USA
Braz J Med Biol Res 35:1139-45. 2002..6%) for the dipyrone group. Intravenous dipyrone is an effective drug for the relief of pain in tension-type headache and its use is justified in the emergency room setting...
Cluster headache as a manifestation of intracranial inflammatory myofibroblastic tumour: a case report with pathophysiological considerationsM E Bigal
Department of Neurology, Albert Einstein College of Medicine and The New England Center for Headache, Stamford, CT 06902, USA
Cephalalgia 23:124-8. 2003....
The clinical spectrum of migraineAlan M Rapoport
Columbia University College of Physicians and Surgeons, New York, NY, USA
Compr Ther 29:35-42. 2003..A structured approach to the patient and a better comprehension of this variability of presentation, should translate into better quality of care for migraineurs...
Chronic daily headache: identification of factors associated with induction and transformationMarcelo E Bigal
Department of Neurology and Epidemiology, Albert Einstein College of Medicine, Bronx, New York, USA
Headache 42:575-81. 2002..As similar results were obtained when CPTH was used as a control, the correlation is more complex than simple comorbidity...
Looking to the future: research designs for study of headache disease progressionRichard B Lipton
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
Headache 48:58-66. 2008....
Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraineMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Office 334-A, Rousso Building, 1165 Morris Park Avenue, Bronx, NY 10461, USA
Headache 43:336-42. 2003..The chronicity and pervasiveness of migraine thus is associated with increased functional impairment as well as increase in headache frequency...
The triptan formulations : how to match patients and productsAlan M Rapoport
Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
CNS Drugs 17:431-47. 2003..Use of the methods outlined in this review in choosing a triptan for an individual patient is probably more likely to lead to migraine relief than making an educated guess as to which triptan is most appropriate...
Concepts and mechanisms of migraine chronificationMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
Headache 48:7-15. 2008..Research on this issue is in its infancy and cautions are necessary before extrapolating this information into clinical practice...
Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled studyMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
Headache 42:862-71. 2002..05 and P<.01) in pain and all associated symptoms compared with control subjects. CONCLUSIONS: Dipyrone is an effective drug for the relief of acute migraine pain and associated symptoms...
Toward an epidemiology of refractory migraine: current knowledge and issues for future researchRichard B Lipton
Departments of Neurology and Epidemiology and Population Health, Albert Einstein College of Medicine, and The Montefiore Headache Center, Bronx, NY, USA
Headache 48:791-8. 2008..The epidemiology of these modifiers is discussed...
Migraine with aura versus migraine without aura: pain intensity and associated symptom intensities after placeboMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
Headache 42:872-7. 2002..CONCLUSIONS: Our findings suggest that studies comparing placebo against an active drug should use stratification according to the presence versus absence of aura...
Headache as a real diseaseRichard B Lipton
Albert Einstein College of Medicine, Bronx, New York, USA
Headache 48:707-10. 2008..Drs. Lipton and Bigal examine the path to acceptance and the impediments that had to be overcome...
Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive casesStewart J Tepper
The New England Center for Headache, Stamford, CT 06902, USA
Headache 44:794-800. 2004..Prospective, controlled studies must be considered for severely disabled, refractory patients...
Patterns of use of triptans and reasons for switching them in a tertiary care migraine populationFred D Sheftell
Department of Psychiatry, New York Medical College, NY, USA
Headache 44:661-8. 2004..To assess this attributes can provide additional information to supplement the traditional tests of efficacy provided by randomized clinical trials...
Modifiable risk factors for migraine progression (or for chronic daily headaches)--clinical lessonsMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Headache 46:S144-6. 2006..These recommendations have not been demonstrated to improve outcomes in longitudinal studies...
Zolmitriptan (Zomig)Alan M Rapoport
College of Physicians and Surgeons, Columbia University, New York, NY, USA
Expert Rev Neurother 4:33-41. 2004..5-mg dose at early time points. The physician can now choose the optimum route of delivery of zolmitriptan to stop the headache, increase the likelihood of reducing disability and restore the patient to complete functionality...
Tools for diagnosing migraine and measuring its severityRichard B Lipton
Department of Neurology, The Albert Einstein College of Medicine, Bronx, NY, USA
Headache 44:387-98. 2004..Migraine is assessed to determine how well it meets criteria for screening and the steps that are necessary before firm public policy recommendations for screening for migraine are possible...
ID-migraineA M Rapoport
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Neurol Sci 25:S258-60. 2004..Herein we briefly discuss reasons for screening migraine in the primary care setting, and focus on the ID-migraine, a validated migraine screening tool...
Preventive migraine therapy: what is newA M Rapoport
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Neurol Sci 25:S177-85. 2004....
Surgical treatment of patients with refractory migraine headaches and intranasal contact pointsF Behin
Mount Sinai Medical Center, New York, NY, USA
Cephalalgia 25:439-43. 2005..Prospective studies are necessary to confirm our results...
Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?Michel Volcy
The New England Center for Headache, Stanford, Connecticut 06902, USA
Headache 45:1083-7. 2005..We hypothesize that the tinnitus intensity increase could be an allodynic symptom related to CS, or alternatively could be associated with cortical hyperexcitability...
Assessment of adverse events associated with triptans--methods of assessment influence the resultsFred D Sheftell
New York Medical College, Psychiatry, New York, NY, USA
Headache 44:978-82. 2004..2) From those subjects who did not self-report adverse events after using a triptan, most of them will report positively if presented with a list of side effects...
The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteriaMarcelo E Bigal
Albert Einstein College of Medicine, Neurology, Bronx, NY, USA
Headache 45:582-9. 2005..iii) About half of the patients with NDPH according to the S-L criteria have too many migraine features to meet ICHD-2 criteria for NDPH...
Multiple cranial neuropathies, headache, and facial pain in a septuagenarianBrian M Grosberg
Albert Einstein College of Medicine, The Montefiore Headache Unit, Bronx, NY, USA
Headache 44:1038-9. 2004
Hemicrania continua: a report of ten new casesMarcelo E Bigal
International Headache Society Fellow, The New England Center for Headache, New York, NY, USA
Arq Neuropsiquiatr 60:695-8. 2002..Although the cardinal features of HC - continuous, unilateral, indomethacin responsive, remain strongly reliable, a refinement on the clinical characterization is needful and desired...
New onset headache in a woman with recurrent ear infectionsBrian M Grosberg
Montefiore Headache Unit, Albert Einstein College of Medicine, Bronx, NY, USA
Headache 45:240-1. 2005
Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 casesAlan M Rapoport
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Headache 43:482-9. 2003..CONCLUSIONS: Naratriptan may have a role in the preventive treatment of intractable chronic migraine. Prospective, controlled studies should be considered...
Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot studyFred D Sheftell
The New England Center for Headache, College of Medicine, Stanford, CT, USA
Headache 45:1400-6. 2005..2) The tolerability of this treatment was excellent. (3) Over a short period of time (3 months), no serious adverse events were reported, nor significant changes were found in the ECG or ophthalmologic evaluation...
Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteriaMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine
Headache 44:684-91. 2004..Clinical trials of this entity should therefore be conducted using the S-L criteria. Finally, we propose that in the 3rd edition of the IHS classification, the diagnosis of NDPH be revised so as not to exclude migraine features...
Modifiable risk factors for migraine progressionMarcelo E Bigal
Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Headache 46:1334-43. 2006..We present the evidence for each risk factor and discuss possible interventions to address them...
